The Great Fragmentation of 2026: Consumer Resilience, Biotech Highs, and Web3 GhostsGlobal Report·Jul 22 at 04:18 AMNG+0.17%AKA-0.27%
10 Health Care Stocks With Whale Alerts In Today’s Sessionbenzinga_article·Jul 21 at 12:35 PMABVX-4.16%MRK+0.45%
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)Unusual Whales·Jul 19 at 04:31 PMIOVA-2.73%
Top Biotech Gainers: APLM Climbs 22%; IOVA, RCEL On Watch; MANE Gains On Hair Loss Datarttnews·Jul 15 at 10:42 PMIOVA-2.73%MANE-5.48%
Iovance Biotherapeutics updates corporate presentation, reiterates $350M–$370M FY26 guidanceTradingView·Jul 2 at 04:03 PMIOVA-2.73%
Iovance publishes corporate presentation on TIL cell therapy platform, Amtagvi launch and pipeline updatesPUBT·Jun 30 at 03:01 PMIOVA-2.73%
Iovance Biotherapeutics (IOVA) Stock Could Be 53.2% Undervalued After New Shelf FilingsSimplywall·Jun 22 at 10:01 PMIOVA-2.73%
Mizuho Securities Sticks to Their Buy Rating for Iovance Biotherapeutics (IOVA)Tip Ranks·Jun 22 at 09:55 AMIOVA-2.73%
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | IOVA Stock NewsStockTitan·Jun 19 at 08:15 AMIOVA-2.73%
